Skip to playerSkip to main content
  • 7 minutes ago
Gene editing and other genomic therapies could one day replace daily medication for common conditions such as high cholesterol, ScienceDaily reports. Two University of Michigan cardiologists argue in JAMA Internal Medicine that safety standards must remain high: one-time treatments may not last a lifetime, the immune system can block repeat doses, and permanent changes cannot simply be stopped if side effects appear. They call for independent, large-scale, long-term monitoring before such therapies can be safely offered to millions of people.

Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools.

Category

🗞
News
Transcript
00:00Imagine one treatment that keeps cholesterol in check for decades.
00:03Gene editing could someday replace a lifetime of daily pills.
00:07Unlike regular medicine, some genetic treatments are designed to work after one dose.
00:12They can add a working gene, silence a harmful one, or edit DNA directly.
00:17Gene therapies already help treat conditions like spinal muscular atrophy and sickle cell disease.
00:22Now researchers are eyeing common problems like high cholesterol, heart disease, and diabetes.
00:28But two University of Michigan cardiologists urge caution in JAMA internal medicine.
00:33One and done doesn't always mean lifelong.
00:35The immune system may block a second dose if benefits fade.
00:39And a permanent change can't simply be stopped if side effects appear.
00:43A rare side effect could still harm many people if millions are treated.
00:47So they call for large-scale, long-term monitoring.
00:50The technology is powerful, but the bar for safety is high.
00:54Disclosure. This video contains stock footage and content created or enhanced using AI-assisted tools.

Recommended